|
1
|
MacNeil DE, Bensoussan HJ and Autexier C:
Telomerase regulation from beginning to the end. Genes (Basel).
7:E642016. View Article : Google Scholar
|
|
2
|
Landa I, Ganly I, Chan TA, Mitsutake N,
Matsuse M, Ibrahimpasic T, Ghossein RA and Fagin JA: Frequent
somatic TERT promoter mutations in thyroid cancer: Higher
prevalence in advanced forms of the disease. J Clin Endocrinol
Metab. 98:E1562–E1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gisselsson D, Jonson T, Petersén A,
Strombeck B, Dal Cin P, Höglund M, Mitelman F, Mertens F and
Mandahl N: Telomere dysfunction triggers extensive DNA
fragmentation and evolution of complex chromosome abnormalities in
human malignant tumors. Proc Natl Acad Sci USA. 98:12683–12688.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bilimoria KY, Shen WT, Elaraj D, Bentrem
DJ, Winchester DJ, Kebebew E and Sturgeon C: Adrenocortical
carcinoma in the United States: Treatment utilization and
prognostic factors. Cancer. 113:3130–3136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Payabyab EC, Balasubramaniam S, Edgerly M,
Velarde M, Merino MJ, Venkatesan AM, Leuva H, Litman T, Bates SE
and Fojo T: Adrenocortical cancer: A molecularly complex disease
where surgery matters. Clin Cancer Res. 22:4989–5000. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Postlewait LM, Ethun CG, Tran TB, Prescott
JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, et
al: Outcomes of adjuvant mitotane after resection of adrenocortical
carcinoma: A 13-institution study by the US adrenocortical
carcinoma group. J Am Coll Surg. 222:480–490. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Juhlin CC, Goh G, Healy JM, Fonseca AL,
Scholl UI, Stenman A, Kunstman JW, Brown TC, Overton JD, Mane SM,
et al: Whole-exome sequencing characterizes the landscape of
somatic mutations and copy number alterations in adrenocortical
carcinoma. J Clin Endocrinol Metab. 100:E493–E502. 2015. View Article : Google Scholar
|
|
8
|
Zheng S, Cherniack AD, Dewal N, Moffitt
RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA,
Ciriello G, et al: Comprehensive pan-genomic characterization of
adrenocortical carcinoma. Cancer Cell. 29:723–736. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Assie G, Letouzé E, Fassnacht M, Jouinot
A, Luscap W, Barreau O, Omeiri H, Rodriguez S, Perlemoine K,
Rene-Corail F, et al: Integrated genomic characterization of
adrenocortical carcinoma. Nat Genet. 46:607–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu T, Brown TC, Juhlin CC, Andreasson A,
Wang N, Bäckdahl M, Healy JM, Prasad ML, Korah R, Carling T, et al:
The activating TERT promoter mutation C228T is recurrent in subsets
of adrenal tumors. Endocr Relat Cancer. 21:427–434. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Else T, Giordano TJ and Hammer GD:
Evaluation of telomere length maintenance mechanisms in
adrenocortical carcinoma. J Clin Endocrinol Metab. 93:1442–1449.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Horn S, Figl A, Rachakonda PS, Fischer C,
Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, et al:
TERT promoter mutations in familial and sporadic melanoma. Science.
339:959–961. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang N, Kjellin H, Sofiadis A, Fotouhi O,
Juhlin CC, Bäckdahl M, Zedenius J, Xu D, Lehtiö J and Larsson C:
Genetic and epigenetic background and protein expression profiles
in relation to telomerase activation in medullary thyroid
carcinoma. Oncotarget. 7:21332–21346. 2016.PubMed/NCBI
|
|
14
|
Renaud S, Loukinov D, Abdullaev Z,
Guilleret I, Bosman FT, Lobanenkov V and Benhattar J: Dual role of
DNA methylation inside and outside of CTCF-binding regions in the
transcriptional regulation of the telomerase hTERT gene. Nucleic
Acids Res. 35:1245–1256. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
DeLellis RA, Lloyd RV, Heitz PU and Eng C:
Pathology and genetics of tumours of endocrine organs. Third
edition. WHO Classification of Tumours; 8. 2004
|
|
16
|
Moran B, Das S, Smeets D, Peutman G,
Klinger R, Fender B, Connor K, Ebert M, Gaiser T, Prehn JH, et al:
Assessment of concordance between fresh-frozen and formalin-fixed
paraffin embedded tumor DNA methylation using a targeted sequencing
approach. Oncotarget. 8:48126–48137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang N, Xu D, Sofiadis A, Höög A,
Vukojević V, Bäckdahl M, Zedenius J and Larsson C:
Telomerase-dependent and independent telomere maintenance and its
clinical implications in medullary thyroid carcinoma. J Clin
Endocrinol Metab. 99:E1571–E1579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cawthon RM: Telomere measurement by
quantitative PCR. Nucleic Acids Res. 30:e472002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mannelli M, Gelmini S, Arnaldi G,
Becherini L, Bemporad D, Crescioli C, Pazzagli M, Mantero F, Serio
M and Orlando C: Telomerase activity is significantly enhanced in
malignant adrenocortical tumors in comparison to benign
adrenocortical adenomas. J Clin Endocrinol Metab. 85:468–470. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kjellman M, Kallioniemi OP, Karhu R, Höög
A, Farnebo LO, Auer G, Larsson C and Bäckdahl M: Genetic
aberrations in adrenocortical tumors detected using comparative
genomic hybridization correlate with tumor size and malignancy.
Cancer Res. 56:4219–4223. 1996.PubMed/NCBI
|
|
21
|
Cao Y, Bryan TM and Reddel RR: Increased
copy number of the TERT and TERC telomerase subunit genes in cancer
cells. Cancer Sci. 99:1092–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hamidi T, Singh AK and Chen T: Genetic
alterations of DNA methylation machinery in human diseases.
Epigenomics. 7:247–265. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jouinot A, Assie G, Libe R, Fassnacht M,
Papathomas T, Barreau O, de la Villeon B, Faillot S, Hamzaoui N,
Neou M, et al: DNA Methylation is an independent prognostic marker
of survival in adrenocortical cancer. J Clin Endocrinol Metab.
102:923–932. 2017.
|
|
24
|
Tabori U, Nanda S, Druker H, Lees J and
Malkin D: Younger age of cancer initiation is associated with
shorter telomere length in Li-Fraumeni syndrome. Cancer Res.
67:1415–1418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hirano Y, Fujita K, Suzuki K, Ushiyama T,
Ohtawara Y and Tsuda F: Telomerase activity as an indicator of
potentially malignant adrenal tumors. Cancer. 83:772–776. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Else T: Telomeres and telomerase in
adrenocortical tissue maintenance, carcinogenesis, and aging. J Mol
Endocrinol. 43:131–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
